Nvidia, Apple, and Eli Lilly: Manufacturing the Future
The great buildout for AI and GLP-1 drugs continues. (00:21) Jason Moser and Matt Argersinger discuss: - How Nvidia continues to deliver in the face of great expectations, but even those great results haven’t kept the market happy with the chipmaker or big tech stocks to start 2025. - Apple and Eli Lilly’s plans to…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Motley Fool Hidden Gems Investing
See all episodes →
Behind The Most Exciting Stock Pop In Years!
The Bond Market Selloff is Showing up in Earnings Reports
Berkshire Hathaway Hasn’t Done This in Over 3 Years
Similar episodes from other shows
More like Motley Fool Hidden Gems Investing →
Nvidia’s Record Setting Run… And Trump’s Powell Pressure Ramps Up 7/15/25
#311: Are We in an AI Bubble?
Inside the Battle for Chips That Will Power Artificial Intelligence
End of an era at Apple, the GLP-1 surprise & top holdings of global fund managers
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.